Cognitive Impairment in the Lateralized Phenotype of Corticobasal Degeneration
Corticobasal degeneration (CBD) is a rare disorder, which normally includes a combination of neurobehavioural features, movement disorders and other manifestations. It is now recognized that CBD patients usually present with two phenotypes: the lateralized phenotype and the dementia phenotype. The a...
Gespeichert in:
Veröffentlicht in: | Dementia and geriatric cognitive disorders 2005-01, Vol.20 (2-3), p.158-162 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 162 |
---|---|
container_issue | 2-3 |
container_start_page | 158 |
container_title | Dementia and geriatric cognitive disorders |
container_volume | 20 |
creator | Moretti, Rita Torre, Paola Antonello, Rodolfo M. Cattaruzza, Tatiana Cazzato, Giuseppe |
description | Corticobasal degeneration (CBD) is a rare disorder, which normally includes a combination of neurobehavioural features, movement disorders and other manifestations. It is now recognized that CBD patients usually present with two phenotypes: the lateralized phenotype and the dementia phenotype. The aim of our work was to determine the nature and the progression of cognitive and behavioural impairment in 10 lateralized CBD patients. In our patients, the most salient aspects of cognitive impairment were: an evident alteration of rapid alternating operative strategies, associated with the evident impairment of set shifting, of executive operations, of operative and sequential procedure and of implementation of judgement and abstract reasoning. The self-activation of retrieval processes is partly preserved in CBD. As all the other types of subcortical impairments, even CBD encompasses both cognitive impairment as well as a wide range of behaviour disturbances, such as progressive alterations of sleep, depression, and of anxiety (with a remarkable incidence of somatic pain). This suggests that in addition to neuropsychological assessment, quantification of the personality behaviour disorder is important for standardizing the diagnosis of subcortical vascular dementia and distinguishing it from any other dementias. |
doi_str_mv | 10.1159/000087299 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_20904826</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20904826</sourcerecordid><originalsourceid>FETCH-LOGICAL-c488t-a0c77bbd218faf23121be4ea7e31820935101e585659ce56d3df251b0b3762b43</originalsourceid><addsrcrecordid>eNqN0c9LHDEUB_AgFbWrh54LZSi04GFsfkx-HcuqdWGxHup5yMy8WbOdSdYkK6x_vam7KPSi75IH78N7hC9Cnwg-I4TrHziXklTrPXREKkpKrWj14bnHpcqzQ_QxxmVWkgt9gA6JwErl6RG6nvqFs8k-QDEbV8aGEVwqrCvSHRRzkyCYwT5CV9zcgfNps4LC98XUh2Rb35hohuIcFuCyS9a7Y7TfmyHCye6doNvLiz_Tq3L--9ds-nNetpVSqTS4lbJpOkpUb3rKCCUNVGAkMKIo1owTTIArLrhugYuOdT3lpMENk4I2FZug79u9q-Dv1xBTPdrYwjAYB34da6EqTTmTb8J8DFeKindAoTTDNMOv_8GlXweXf1tTRistCGUZnW5RG3yMAfp6FexowqYmuP6XWf2SWbZfdgvXzQjdq9yFlMG3HTCxNUMfjGttfHUSUy0Jzu7z1v01YQHhBWzPPAEm7qTI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>232496123</pqid></control><display><type>article</type><title>Cognitive Impairment in the Lateralized Phenotype of Corticobasal Degeneration</title><source>MEDLINE</source><source>Karger Journals</source><creator>Moretti, Rita ; Torre, Paola ; Antonello, Rodolfo M. ; Cattaruzza, Tatiana ; Cazzato, Giuseppe</creator><creatorcontrib>Moretti, Rita ; Torre, Paola ; Antonello, Rodolfo M. ; Cattaruzza, Tatiana ; Cazzato, Giuseppe</creatorcontrib><description>Corticobasal degeneration (CBD) is a rare disorder, which normally includes a combination of neurobehavioural features, movement disorders and other manifestations. It is now recognized that CBD patients usually present with two phenotypes: the lateralized phenotype and the dementia phenotype. The aim of our work was to determine the nature and the progression of cognitive and behavioural impairment in 10 lateralized CBD patients. In our patients, the most salient aspects of cognitive impairment were: an evident alteration of rapid alternating operative strategies, associated with the evident impairment of set shifting, of executive operations, of operative and sequential procedure and of implementation of judgement and abstract reasoning. The self-activation of retrieval processes is partly preserved in CBD. As all the other types of subcortical impairments, even CBD encompasses both cognitive impairment as well as a wide range of behaviour disturbances, such as progressive alterations of sleep, depression, and of anxiety (with a remarkable incidence of somatic pain). This suggests that in addition to neuropsychological assessment, quantification of the personality behaviour disorder is important for standardizing the diagnosis of subcortical vascular dementia and distinguishing it from any other dementias.</description><identifier>ISSN: 1420-8008</identifier><identifier>EISSN: 1421-9824</identifier><identifier>DOI: 10.1159/000087299</identifier><identifier>PMID: 16088142</identifier><identifier>CODEN: DGCDFX</identifier><language>eng</language><publisher>Basel, Switzerland: Karger</publisher><subject>Aged ; Basal Ganglia - pathology ; Behavior - physiology ; Biological and medical sciences ; Cerebral Cortex - pathology ; Cognition Disorders - etiology ; Cognition Disorders - psychology ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Disease Progression ; Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes ; Female ; Functional Laterality - physiology ; Humans ; Magnetic Resonance Imaging ; Male ; Medical sciences ; Memory - physiology ; Middle Aged ; Nervous system (semeiology, syndromes) ; Neurodegenerative Diseases - complications ; Neurodegenerative Diseases - psychology ; Neurology ; Neuropharmacology ; Neuropsychological Tests ; Original Research Article ; Pharmacology. Drug treatments ; Psychiatric Status Rating Scales ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Treatment Outcome</subject><ispartof>Dementia and geriatric cognitive disorders, 2005-01, Vol.20 (2-3), p.158-162</ispartof><rights>2005 S. Karger AG, Basel</rights><rights>2005 INIST-CNRS</rights><rights>Copyright (c) 2005 S. Karger AG, Basel.</rights><rights>Copyright (c) 2005 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c488t-a0c77bbd218faf23121be4ea7e31820935101e585659ce56d3df251b0b3762b43</citedby><cites>FETCH-LOGICAL-c488t-a0c77bbd218faf23121be4ea7e31820935101e585659ce56d3df251b0b3762b43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,2429,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17029710$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16088142$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moretti, Rita</creatorcontrib><creatorcontrib>Torre, Paola</creatorcontrib><creatorcontrib>Antonello, Rodolfo M.</creatorcontrib><creatorcontrib>Cattaruzza, Tatiana</creatorcontrib><creatorcontrib>Cazzato, Giuseppe</creatorcontrib><title>Cognitive Impairment in the Lateralized Phenotype of Corticobasal Degeneration</title><title>Dementia and geriatric cognitive disorders</title><addtitle>Dement Geriatr Cogn Disord</addtitle><description>Corticobasal degeneration (CBD) is a rare disorder, which normally includes a combination of neurobehavioural features, movement disorders and other manifestations. It is now recognized that CBD patients usually present with two phenotypes: the lateralized phenotype and the dementia phenotype. The aim of our work was to determine the nature and the progression of cognitive and behavioural impairment in 10 lateralized CBD patients. In our patients, the most salient aspects of cognitive impairment were: an evident alteration of rapid alternating operative strategies, associated with the evident impairment of set shifting, of executive operations, of operative and sequential procedure and of implementation of judgement and abstract reasoning. The self-activation of retrieval processes is partly preserved in CBD. As all the other types of subcortical impairments, even CBD encompasses both cognitive impairment as well as a wide range of behaviour disturbances, such as progressive alterations of sleep, depression, and of anxiety (with a remarkable incidence of somatic pain). This suggests that in addition to neuropsychological assessment, quantification of the personality behaviour disorder is important for standardizing the diagnosis of subcortical vascular dementia and distinguishing it from any other dementias.</description><subject>Aged</subject><subject>Basal Ganglia - pathology</subject><subject>Behavior - physiology</subject><subject>Biological and medical sciences</subject><subject>Cerebral Cortex - pathology</subject><subject>Cognition Disorders - etiology</subject><subject>Cognition Disorders - psychology</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Disease Progression</subject><subject>Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes</subject><subject>Female</subject><subject>Functional Laterality - physiology</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Memory - physiology</subject><subject>Middle Aged</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurodegenerative Diseases - complications</subject><subject>Neurodegenerative Diseases - psychology</subject><subject>Neurology</subject><subject>Neuropharmacology</subject><subject>Neuropsychological Tests</subject><subject>Original Research Article</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychiatric Status Rating Scales</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Treatment Outcome</subject><issn>1420-8008</issn><issn>1421-9824</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqN0c9LHDEUB_AgFbWrh54LZSi04GFsfkx-HcuqdWGxHup5yMy8WbOdSdYkK6x_vam7KPSi75IH78N7hC9Cnwg-I4TrHziXklTrPXREKkpKrWj14bnHpcqzQ_QxxmVWkgt9gA6JwErl6RG6nvqFs8k-QDEbV8aGEVwqrCvSHRRzkyCYwT5CV9zcgfNps4LC98XUh2Rb35hohuIcFuCyS9a7Y7TfmyHCye6doNvLiz_Tq3L--9ds-nNetpVSqTS4lbJpOkpUb3rKCCUNVGAkMKIo1owTTIArLrhugYuOdT3lpMENk4I2FZug79u9q-Dv1xBTPdrYwjAYB34da6EqTTmTb8J8DFeKindAoTTDNMOv_8GlXweXf1tTRistCGUZnW5RG3yMAfp6FexowqYmuP6XWf2SWbZfdgvXzQjdq9yFlMG3HTCxNUMfjGttfHUSUy0Jzu7z1v01YQHhBWzPPAEm7qTI</recordid><startdate>20050101</startdate><enddate>20050101</enddate><creator>Moretti, Rita</creator><creator>Torre, Paola</creator><creator>Antonello, Rodolfo M.</creator><creator>Cattaruzza, Tatiana</creator><creator>Cazzato, Giuseppe</creator><general>Karger</general><general>S. Karger AG</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>88J</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2P</scope><scope>M2R</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20050101</creationdate><title>Cognitive Impairment in the Lateralized Phenotype of Corticobasal Degeneration</title><author>Moretti, Rita ; Torre, Paola ; Antonello, Rodolfo M. ; Cattaruzza, Tatiana ; Cazzato, Giuseppe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c488t-a0c77bbd218faf23121be4ea7e31820935101e585659ce56d3df251b0b3762b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Aged</topic><topic>Basal Ganglia - pathology</topic><topic>Behavior - physiology</topic><topic>Biological and medical sciences</topic><topic>Cerebral Cortex - pathology</topic><topic>Cognition Disorders - etiology</topic><topic>Cognition Disorders - psychology</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Disease Progression</topic><topic>Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes</topic><topic>Female</topic><topic>Functional Laterality - physiology</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Memory - physiology</topic><topic>Middle Aged</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurodegenerative Diseases - complications</topic><topic>Neurodegenerative Diseases - psychology</topic><topic>Neurology</topic><topic>Neuropharmacology</topic><topic>Neuropsychological Tests</topic><topic>Original Research Article</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychiatric Status Rating Scales</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moretti, Rita</creatorcontrib><creatorcontrib>Torre, Paola</creatorcontrib><creatorcontrib>Antonello, Rodolfo M.</creatorcontrib><creatorcontrib>Cattaruzza, Tatiana</creatorcontrib><creatorcontrib>Cazzato, Giuseppe</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Science Database</collection><collection>Social Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Dementia and geriatric cognitive disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moretti, Rita</au><au>Torre, Paola</au><au>Antonello, Rodolfo M.</au><au>Cattaruzza, Tatiana</au><au>Cazzato, Giuseppe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cognitive Impairment in the Lateralized Phenotype of Corticobasal Degeneration</atitle><jtitle>Dementia and geriatric cognitive disorders</jtitle><addtitle>Dement Geriatr Cogn Disord</addtitle><date>2005-01-01</date><risdate>2005</risdate><volume>20</volume><issue>2-3</issue><spage>158</spage><epage>162</epage><pages>158-162</pages><issn>1420-8008</issn><eissn>1421-9824</eissn><coden>DGCDFX</coden><abstract>Corticobasal degeneration (CBD) is a rare disorder, which normally includes a combination of neurobehavioural features, movement disorders and other manifestations. It is now recognized that CBD patients usually present with two phenotypes: the lateralized phenotype and the dementia phenotype. The aim of our work was to determine the nature and the progression of cognitive and behavioural impairment in 10 lateralized CBD patients. In our patients, the most salient aspects of cognitive impairment were: an evident alteration of rapid alternating operative strategies, associated with the evident impairment of set shifting, of executive operations, of operative and sequential procedure and of implementation of judgement and abstract reasoning. The self-activation of retrieval processes is partly preserved in CBD. As all the other types of subcortical impairments, even CBD encompasses both cognitive impairment as well as a wide range of behaviour disturbances, such as progressive alterations of sleep, depression, and of anxiety (with a remarkable incidence of somatic pain). This suggests that in addition to neuropsychological assessment, quantification of the personality behaviour disorder is important for standardizing the diagnosis of subcortical vascular dementia and distinguishing it from any other dementias.</abstract><cop>Basel, Switzerland</cop><pub>Karger</pub><pmid>16088142</pmid><doi>10.1159/000087299</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1420-8008 |
ispartof | Dementia and geriatric cognitive disorders, 2005-01, Vol.20 (2-3), p.158-162 |
issn | 1420-8008 1421-9824 |
language | eng |
recordid | cdi_proquest_miscellaneous_20904826 |
source | MEDLINE; Karger Journals |
subjects | Aged Basal Ganglia - pathology Behavior - physiology Biological and medical sciences Cerebral Cortex - pathology Cognition Disorders - etiology Cognition Disorders - psychology Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Disease Progression Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes Female Functional Laterality - physiology Humans Magnetic Resonance Imaging Male Medical sciences Memory - physiology Middle Aged Nervous system (semeiology, syndromes) Neurodegenerative Diseases - complications Neurodegenerative Diseases - psychology Neurology Neuropharmacology Neuropsychological Tests Original Research Article Pharmacology. Drug treatments Psychiatric Status Rating Scales Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Treatment Outcome |
title | Cognitive Impairment in the Lateralized Phenotype of Corticobasal Degeneration |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T01%3A41%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cognitive%20Impairment%20in%20the%20Lateralized%20Phenotype%20of%20Corticobasal%20Degeneration&rft.jtitle=Dementia%20and%20geriatric%20cognitive%20disorders&rft.au=Moretti,%20Rita&rft.date=2005-01-01&rft.volume=20&rft.issue=2-3&rft.spage=158&rft.epage=162&rft.pages=158-162&rft.issn=1420-8008&rft.eissn=1421-9824&rft.coden=DGCDFX&rft_id=info:doi/10.1159/000087299&rft_dat=%3Cproquest_pubme%3E20904826%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=232496123&rft_id=info:pmid/16088142&rfr_iscdi=true |